327 related articles for article (PubMed ID: 27465265)
41. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.
Lu CJ; Sun Y; Muo CH; Chen RC; Chen PC; Hsu CY
Cerebrovasc Dis; 2013; 36(2):145-51. PubMed ID: 24029780
[TBL] [Abstract][Full Text] [Related]
42. Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance.
Durbin RJ
Diabetes Obes Metab; 2004 Jul; 6(4):280-5. PubMed ID: 15171752
[TBL] [Abstract][Full Text] [Related]
43. Pioglitazone for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis.
Lee M; Saver JL; Liao HW; Lin CH; Ovbiagele B
Stroke; 2017 Feb; 48(2):388-393. PubMed ID: 27999139
[TBL] [Abstract][Full Text] [Related]
44. Insulin resistance and cardiovascular outcomes in the ORIGIN trial.
Gerstein HC; Ferrannini E; Riddle MC; Yusuf S;
Diabetes Obes Metab; 2018 Mar; 20(3):564-570. PubMed ID: 28895655
[TBL] [Abstract][Full Text] [Related]
45. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.
Nissen SE; Nicholls SJ; Wolski K; Nesto R; Kupfer S; Perez A; Jure H; De Larochellière R; Staniloae CS; Mavromatis K; Saw J; Hu B; Lincoff AM; Tuzcu EM;
JAMA; 2008 Apr; 299(13):1561-73. PubMed ID: 18378631
[TBL] [Abstract][Full Text] [Related]
46. Twelve weeks of pioglitazone therapy significantly attenuates dysmetabolism and reduces inflammation in continuous ambulatory peritoneal dialysis patients--a randomized crossover trial.
Li Y; Xie QH; You HZ; Tian J; Hao CM; Lin SY; Zhu TY
Perit Dial Int; 2012; 32(5):507-15. PubMed ID: 22383630
[TBL] [Abstract][Full Text] [Related]
47. Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).
Wilcox R; Kupfer S; Erdmann E;
Am Heart J; 2008 Apr; 155(4):712-7. PubMed ID: 18371481
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke.
Kernan WN; Viscoli CM; Inzucchi SE; Brass LM; Bravata DM; Shulman GI; McVeety JC
Arch Intern Med; 2005 Jan; 165(2):227-33. PubMed ID: 15668371
[TBL] [Abstract][Full Text] [Related]
49. Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary Syndrome.
Stähli BE; Nozza A; Schrieks IC; Buse JB; Malmberg K; Mellbin L; Neal B; Nicholls SJ; Rydén L; Svensson A; Wedel H; Weichert A; Lincoff AM; Grobbee DE; Tardif JC; Schwartz GG
J Clin Endocrinol Metab; 2018 Jul; 103(7):2522-2533. PubMed ID: 29659887
[TBL] [Abstract][Full Text] [Related]
50. [Associations of insulin resistance and pancreatic beta-cell function with plasma glucose level in type 2 diabetes].
Nian X; Sun G; Dou C; Hou H; Fan X; Yu H; Ma L; He B
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):732-5. PubMed ID: 12126540
[TBL] [Abstract][Full Text] [Related]
51. Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA.
Lundström A; Laska AC; Von Arbin M; Jörneskog G; Wallén H
Platelets; 2014; 25(2):102-10. PubMed ID: 23527528
[TBL] [Abstract][Full Text] [Related]
52. The effect of dehydroepiandrosterone on insulin resistance in patients with impaired glucose tolerance.
Talaei A; Amini M; Siavash M; Zare M
Hormones (Athens); 2010; 9(4):326-31. PubMed ID: 21112864
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM.
Perez A; Zhao Z; Jacks R; Spanheimer R
Curr Med Res Opin; 2009 Dec; 25(12):2915-23. PubMed ID: 19827910
[TBL] [Abstract][Full Text] [Related]
54. Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.
Derosa G; Mereu R; Salvadeo SA; D'Angelo A; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
Intern Med; 2009; 48(5):265-71. PubMed ID: 19252346
[TBL] [Abstract][Full Text] [Related]
55. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
Belfort R; Harrison SA; Brown K; Darland C; Finch J; Hardies J; Balas B; Gastaldelli A; Tio F; Pulcini J; Berria R; Ma JZ; Dwivedi S; Havranek R; Fincke C; DeFronzo R; Bannayan GA; Schenker S; Cusi K
N Engl J Med; 2006 Nov; 355(22):2297-307. PubMed ID: 17135584
[TBL] [Abstract][Full Text] [Related]
56. Effect of pioglitazone on vascular events in post-stroke cognitive impairment: Post hoc analysis of the IRIS trial.
Schmidt K; Power MC; Ciarleglio A; Nadareishvili Z
Int J Stroke; 2024 Apr; 19(4):414-421. PubMed ID: 38148372
[TBL] [Abstract][Full Text] [Related]
57. Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance.
Espinoza SE; Wang CP; Tripathy D; Clement SC; Schwenke DC; Banerji MA; Bray GA; Buchanan TA; Henry RR; Kitabchi AE; Mudaliar S; Stentz FB; Reaven PD; DeFronzo RA; Musi N
Age (Dordr); 2016 Dec; 38(5-6):485-493. PubMed ID: 27585671
[TBL] [Abstract][Full Text] [Related]
58. Investigating the changes in the levels of HbA1c, blood fat and insulin sensitivity in elder patients with type II diabetes mellitus due to combined medication of pioglitazone and melbine and single-use of pioglitazone.
Sun Y; Yu Q; Xie J
Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):21-28. PubMed ID: 33040780
[TBL] [Abstract][Full Text] [Related]
59. Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats.
Clark M; Thomaseth K; Dirikolu L; Ferguson DC; Hoenig M
J Vet Intern Med; 2014; 28(1):166-74. PubMed ID: 24592408
[TBL] [Abstract][Full Text] [Related]
60. Long-term effects of pioglitazone on first attack of ischemic cerebrovascular disease in older people with type 2 diabetes: A case-control study in Taiwan.
Lai SW; Lin HF; Lin CL; Liao KF
Medicine (Baltimore); 2016 Aug; 95(31):e4455. PubMed ID: 27495077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
